• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

四种膀胱过度活动症患者问卷的重测信度:膀胱过度活动症问卷(OAB-q)、患者膀胱状况感知问卷(PPBC)、尿急问卷(UQ)以及原发性膀胱过度活动症症状问卷(POSQ)。

Test-retest reliability of four questionnaires for patients with overactive bladder: the overactive bladder questionnaire (OAB-q), patient perception of bladder condition (PPBC), urgency questionnaire (UQ), and the primary OAB symptom questionnaire (POSQ).

作者信息

Matza Louis S, Thompson Christine L, Krasnow Joel, Brewster-Jordan Jessica, Zyczynski Teresa, Coyne Karin S

机构信息

MEDTAP International, Inc., Bethesda, Maryland 20814, USA.

出版信息

Neurourol Urodyn. 2005;24(3):215-25. doi: 10.1002/nau.20110.

DOI:10.1002/nau.20110
PMID:15747340
Abstract

AIMS

This study examined test-retest reliability of four patient-reported outcome measures for patients with overactive bladder (OAB): Overactive Bladder Questionnaire (OAB-q), Patient Perception of Bladder Condition (PPBC), Urgency Questionnaire (UQ), and Primary OAB Symptom Questionnaire (POSQ).

METHODS

Patients recruited from urology clinics were scheduled for two visits 2 weeks apart and completed all questionnaires at both visits. A demographic form was completed at Visit 1; and a treatment effect scale was completed at Visit 2. Test-retest reliability was examined among stable patients using intraclass correlations (ICC), Spearman's correlations, paired t-tests, Feldt's statistic, and kappas.

RESULTS

A total of 47 patients enrolled (mean age = 66.0 years, 74.5% female), with 46 completing both visits; 35 were classified stable. Statistically significant correlations were present between Visits 1 and 2 (P < 0.05) for all subscales of the OAB-q, UQ, and POSQ. Subscale ICCs were moderate to high (OAB-q > or = 0.83, UQ > or = 0.46, POSQ continuous items > or = 0.68). No significant differences between Visit 1 and 2 were noted, except for the OAB-q symptom bother scale (change of 5.8 points on a 100-point scale). The multi-item subscales of the OAB-q and the UQ demonstrated good internal consistency (Cronbach's alpha > or = 0.83 for all subscales) across both visits. Test-retest reliability of the PPBC was somewhat weaker than the other three measures, but still acceptable for use as a global, single-item outcome measure.

CONCLUSIONS

The OAB-q, POSQ, and UQ demonstrated good test-retest reliability, with ICCs roughly equivalent or superior to those previously reported for 7-day micturition diaries. Findings suggest that the four measures examined in this study demonstrate the necessary reproducibility for use as outcome measures for OAB treatments.

摘要

目的

本研究考察了膀胱过度活动症(OAB)患者的四种患者报告结局指标的重测信度,这四种指标分别为:膀胱过度活动症问卷(OAB-q)、患者对膀胱状况的感知(PPBC)、尿急问卷(UQ)以及主要OAB症状问卷(POSQ)。

方法

从泌尿外科诊所招募患者,安排他们在相隔2周的时间进行两次就诊,并在两次就诊时完成所有问卷。在第一次就诊时填写一份人口统计学表格;在第二次就诊时填写一份治疗效果量表。使用组内相关系数(ICC)、Spearman相关系数、配对t检验、Feldt统计量和kappa系数对病情稳定的患者进行重测信度检验。

结果

共纳入47例患者(平均年龄 = 66.0岁,74.5%为女性),其中46例完成了两次就诊;35例被归类为病情稳定。OAB-q、UQ和POSQ的所有子量表在第一次和第二次就诊之间均存在统计学显著相关性(P < 0.05)。子量表的ICC为中度至高度(OAB-q≥0.83,UQ≥0.46,POSQ连续项目≥0.68)。除了OAB-q症状困扰量表(在100分制上变化了5.8分)外,第一次和第二次就诊之间未发现显著差异。OAB-q和UQ的多项目子量表在两次就诊中均表现出良好的内部一致性(所有子量表的Cronbach's α≥0.83)。PPBC的重测信度略低于其他三项指标,但作为一项整体的单项结局指标仍可接受。

结论

OAB-q、POSQ和UQ表现出良好的重测信度,其ICC大致等同于或优于先前报道的7天排尿日记的ICC。研究结果表明,本研究中考察的这四项指标具有用作OAB治疗结局指标所需的可重复性。

相似文献

1
Test-retest reliability of four questionnaires for patients with overactive bladder: the overactive bladder questionnaire (OAB-q), patient perception of bladder condition (PPBC), urgency questionnaire (UQ), and the primary OAB symptom questionnaire (POSQ).四种膀胱过度活动症患者问卷的重测信度:膀胱过度活动症问卷(OAB-q)、患者膀胱状况感知问卷(PPBC)、尿急问卷(UQ)以及原发性膀胱过度活动症症状问卷(POSQ)。
Neurourol Urodyn. 2005;24(3):215-25. doi: 10.1002/nau.20110.
2
The validation of the patient perception of bladder condition (PPBC): a single-item global measure for patients with overactive bladder.膀胱状况患者感知(PPBC)的验证:一种用于膀胱过度活动症患者的单项整体测量方法。
Eur Urol. 2006 Jun;49(6):1079-86. doi: 10.1016/j.eururo.2006.01.007. Epub 2006 Jan 24.
3
Relationships between improvements in symptoms and patient assessments of bladder condition, symptom bother and health-related quality of life in patients with overactive bladder treated with tolterodine.用托特罗定治疗的膀胱过度活动症患者症状改善与膀胱状况、症状困扰及健康相关生活质量的患者评估之间的关系。
Int J Clin Pract. 2008 Jun;62(6):925-31. doi: 10.1111/j.1742-1241.2008.01778.x.
4
The psychometric validation of the OAB family impact measure (OAB-FIM).OAB 家庭影响量表(OAB-FIM)的心理测量学验证。
Neurourol Urodyn. 2010 Mar;29(3):359-69. doi: 10.1002/nau.20715.
5
Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder: the VESIcare Open-Label Trial (VOLT).索利那新治疗膀胱过度活动症后的症状困扰及健康相关生活质量结局:卫喜康开放标签试验(VOLT)
Clin Ther. 2006 Nov;28(11):1935-46. doi: 10.1016/j.clinthera.2006.11.010.
6
Symptom severity and patient perceptions in overactive bladder: how are they related?膀胱过度活动症的症状严重程度和患者感知:它们之间有何关联?
BJU Int. 2009 Oct;104(7):968-72. doi: 10.1111/j.1464-410X.2009.08498.x. Epub 2009 Mar 10.
7
Psychometric validation of the overactive bladder satisfaction with treatment questionnaire (OAB-SAT-q).膀胱过度活动症治疗满意度问卷(OAB-SAT-q)的心理测量学验证
Neurourol Urodyn. 2009;28(5):416-22. doi: 10.1002/nau.20672.
8
Solifenacin for overactive bladder with incontinence: symptom bother and health-related quality of life outcomes.索利那新用于治疗伴有尿失禁的膀胱过度活动症:症状困扰及与健康相关的生活质量结果
Ann Pharmacother. 2007 Mar;41(3):391-8. doi: 10.1345/aph.1H581. Epub 2007 Mar 6.
9
Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence.托特罗定缓释片对患有膀胱过度活动症和急迫性尿失禁的性活跃女性患者报告结局的影响。
Curr Med Res Opin. 2009 Sep;25(9):2159-65. doi: 10.1185/03007990903103279.
10
Development and validation of the Overactive Bladder Satisfaction (OAB-S) Questionnaire.膀胱过度活动症满意度(OAB-S)问卷的编制与验证
Neurourol Urodyn. 2008;27(3):179-90. doi: 10.1002/nau.20455.

引用本文的文献

1
Examining Symptom Management and Quality of Life of Loop Diuretic-Induced Overactive Bladder Among Heart Failure Patients: Physician and Patient Perspectives.心力衰竭患者中襻利尿剂所致膀胱过度活动症的症状管理与生活质量:医生与患者视角
J Patient Exp. 2025 Feb 6;12:23743735251316416. doi: 10.1177/23743735251316416. eCollection 2025.
2
Risk factors, urodynamic characteristics, and distress associated with nocturnal enuresis in overactive bladder -wet women.膀胱过度活动症伴遗尿女性的危险因素、尿动力学特征及相关困扰
Sci Rep. 2025 Jan 2;15(1):235. doi: 10.1038/s41598-024-84031-w.
3
A 5-year natural history cohort of patients with facioscapulohumeral muscular dystrophy determining disease progression and feasibility of clinical outcome assessments for clinical trials.
一项关于面肩肱型肌营养不良患者的5年自然史队列研究,以确定疾病进展及临床试验临床结局评估的可行性。
Muscle Nerve. 2025 Jan;71(1):55-62. doi: 10.1002/mus.28293. Epub 2024 Nov 7.
4
Beneficial effects of saw palmetto () fruit extract on the urinary symptoms of healthy Japanese adults with possible lower urinary tract symptoms: A randomized, double-blind, placebo-controlled study.锯叶棕果实提取物对可能存在下尿路症状的健康日本成年人泌尿系统症状的有益作用:一项随机、双盲、安慰剂对照研究。
Nutr Health. 2024 Jul 23:2601060241265389. doi: 10.1177/02601060241265389.
5
Reduced versus standard intradetrusor OnabotulinumtoxinA injections for treatment of overactive bladder.减少与标准的膀胱内注射肉毒杆菌毒素 A 治疗膀胱过度活动症。
Neurourol Urodyn. 2023 Jan;42(1):366-374. doi: 10.1002/nau.25107. Epub 2022 Dec 1.
6
Effect of Deep Brain Stimulation on Female Parkinsonian Patients with Lower Urinary Tract Symptoms.脑深部电刺激对伴有下尿路症状的女性帕金森病患者的影响。
Neuropsychiatr Dis Treat. 2021 Dec 18;17:3727-3733. doi: 10.2147/NDT.S342236. eCollection 2021.
7
Validating 7-items Overactive Bladder Symptom Score (OABSS) through Arabic linguistic version.验证阿拉伯语版本的 7 项膀胱过度活动症症状评分(OABSS)。
Sci Rep. 2021 Jan 12;11(1):661. doi: 10.1038/s41598-020-79974-9.
8
Assessment of the validity and reliability of the 32-item Motor Function Measure in individuals with Type 2 or non-ambulant Type 3 spinal muscular atrophy.评估 32 项运动功能测量在 2 型或非卧床 3 型脊髓性肌萎缩症患者中的有效性和可靠性。
PLoS One. 2020 Sep 18;15(9):e0238786. doi: 10.1371/journal.pone.0238786. eCollection 2020.
9
Validity and Reliability of the 32-Item Motor Function Measure in 2- to 5-Year-Olds with Neuromuscular Disorders and 2- to 25-Year-Olds with Spinal Muscular Atrophy.32项运动功能测量量表在2至5岁神经肌肉疾病患儿及2至25岁脊髓性肌萎缩症患者中的效度和信度
Neurol Ther. 2020 Dec;9(2):575-584. doi: 10.1007/s40120-020-00206-3. Epub 2020 Aug 27.
10
Urinary incontinence in female university students.女性大学生尿失禁。
Int Urogynecol J. 2021 Feb;32(2):367-373. doi: 10.1007/s00192-020-04360-y. Epub 2020 Jun 8.